LING LI: Open Payments
NPI 1417135195 · HARTFORD, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$430 in 17 payments from 9 companies in 2025. Trend: 2023 $65 · 2024 $536 · 2025 $430
Food & beverage: $430
| Company | Payments | Amount |
|---|---|---|
| Exact Sciences Corporation | 3 | $87 |
| Otsuka America Pharmaceutical, Inc. | 3 | $59 |
| Neurocrine BioSciences, Inc. | 2 | $55 |
| Lilly USA, LLC | 2 | $55 |
| Lundbeck LLC | 2 | $49 |
| Teva Pharmaceuticals USA, Inc. | 2 | $40 |
| Actelion Pharmaceuticals US, Inc. | 1 | $38 |
| Vanda Pharmaceuticals Inc. | 1 | $30 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $17 |
Products named: REXULTI, Cologuard Collection Kit, INGREZZA, MOUNJARO, AUSTEDO XR, OPSUMIT, FANAPT, XIFAXAN.
Industry payments across CT — which companies pay providers there.
